Article metrics

Download PDFPDF

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52

 

Online download statistics by month:

Online download statistics by month: July 2020 to December 2021

AbstractFullPdf
Jul 202011341128648
Aug 2020794776423
Sep 202018241810478
Oct 202016061590269
Nov 2020296288256
Dec 2020206195124
Jan 2021223211165
Feb 2021194193105
Mar 2021186181130
Apr 2021148141104
May 2021176164114
Jun 2021899572
Jul 202110911156
Aug 202112012488
Sep 202114013788
Oct 2021188188122
Nov 2021148147128
Dec 2021929664
Total767375753434